Sponsor study identifier
interventional
35
1 country
1
Study Start
December 13, 2022
Actual (reported)Primary Completion
December 15, 2022
Actual (reported)Study Completion
May 12, 2023
Actual (reported)The study aims to assess the effect of Profilm Mouth Sores treatment for relieving symptoms caused by mouth sores. It will involve 35 participants and last around 14 days or until the sores heal, with three daily applications. A dermatology specialist will evaluate the results through tests and examinations of the treated area.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
May 12, 2023
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
December 13, 2022
Actual (reported)December 15, 2022
Actual (reported)May 12, 2023
Actual (reported)December 11, 2024
Actual (reported)December 18, 2024
Actual (reported)Confirm the effectiveness of the treatment in terms of pain relief, using an EVA scale.
For the evaluation of effectiveness, a 0 to 10 EVA scale is used (where 0 = no pain / 10 = severe or unbearable pain).
At baseline, in 24 hours, in 3 days, in 7 days and in 14 days.
Serious adverse events.
Evaluate the safety of the treatment, in terms of the incidence of serious adverse events.
Through study completion, apprroximately 2 weeks.
Mild adverse events.
Through study completion, apprroximately 2 weeks.
Healin time and lesion size.
At baseline, in 24 hours, in 3 days, in 7 days and in 14 days.
Global treatment assessment by participants.
At the conclusion of the study, approximately 2 weeks later.
To evaluate the efficacy and safety of the Profilm Mouth Sores for the treatment of mouth sores.
Daily applications of the product as soon as a mouth sore appears, until its complete disappearance or healing, as follows: application every 8 hours, with the possibility of shortening the interval to 6 hours if needed (a maximum of 3-4 applications).
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Centro Médico Complutense Grupo Virtus
Alcalá de Henares, Madrid, 28805, Spain
35 participants (actual enrollment reported by the registry).
First Submitted
December 11, 2024
First Posted
December 18, 2024
Study Start
December 13, 2022
Actual (reported)Contact the study team to confirm eligibility.
Primary Completion
December 15, 2022
Actual (reported)Study Completion
May 12, 2023
Actual (reported)Last Updated
April 25, 2025
Record last verified: 2025-04
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: